» Articles » PMID: 24184920

Hippocampal Subregion-specific MicroRNA Expression During Epileptogenesis in Experimental Temporal Lobe Epilepsy

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2013 Nov 5
PMID 24184920
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Since aberrant miRNA expression has been implicated in numerous brain diseases, we studied miRNA expression and miRNA regulation of important signaling pathways during temporal lobe epileptogenesis in order to identify possible targets for epilepsy therapy. The temporal profile of miRNA expression was analyzed in three brain regions (CA1; dentate gyrus, DG; parahippocampal cortex, PHC) associated with epileptogenesis in a rat model for temporal lobe epilepsy. Tissue was obtained after electrically-induced status epilepticus (SE) at 1day (n=5), 1week (n=5) and 3-4months (n=5), and compared with control tissue (n=10) using the Exiqon microRNA arrays which contain capture probes targeting all miRNAs for rat (p<0.01, and a 1.5 fold up- or downregulation). Expression of three blood plasma miRNAs from the same group of rats was also investigated in rats in order to determine whether plasma miRNAs could serve as potential biomarkers of the epileptogenic process. Molecular pathways potentially altered by the expression of multiple miRNAs were identified using a web-based algorithm, DIANA. In CA1 and DG, more upregulated than downregulated miRNAs were present during each stage after SE. The highest numbers of upregulated miRNAs were encountered during the chronic stage in the DG. In PHC, a high number of downregulated miRNAs were detected. Key pathways involved, based upon quantitatively altered miRNA expression were: axon guidance, MAPK signaling pathway, focal adhesion, TGFβ, ErbB-, Wnt- and mTOR signaling, and regulation of actin skeleton. Expression of plasma miRNAs was differentially regulated after induction of SE. This study identified several signaling pathways possibly involved in temporal lobe epileptogenesis, not previously indicated by RNA microarray studies. These include miRNAs that regulate the ErbB and Wnt pathways and focal adhesion, which may represent interesting new targets for therapeutic interventions.

Citing Articles

Identification of plasma exosomal microRNAs and bioinformatics analysis of the microRNA-messenger RNA regulatory pathways in mice with status epilepticus.

Wang W, Yin J Cytotechnology. 2025; 77(2):65.

PMID: 39991702 PMC: 11842689. DOI: 10.1007/s10616-025-00708-8.


Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study.

Bertoli G, Fortunato F, Cava C, Manna I, Gallivanone F, Labate A Curr Neuropharmacol. 2024; 22(14):2422-2432.

PMID: 39403059 PMC: 11451323. DOI: 10.2174/1570159X22666240516145823.


Profile of miRNA expression in the hippocampus of epileptic mice and the prediction of potential therapeutic targets.

Tan Y, Yu Y, Niu H, Wang C, Mo P, Li D Mol Biol Rep. 2024; 51(1):929.

PMID: 39172288 DOI: 10.1007/s11033-024-09861-3.


Integrative network analysis of miRNA-mRNA expression profiles during epileptogenesis in rats reveals therapeutic targets after emergence of first spontaneous seizure.

Khemka N, Morris G, Kazemzadeh L, Costard L, Neubert V, Bauer S Sci Rep. 2024; 14(1):15313.

PMID: 38961125 PMC: 11222454. DOI: 10.1038/s41598-024-66117-7.


Strategic pathway analysis for dual management of epilepsy and comorbid depression: a systems biology perspective.

Kaur A, Raji , Verma V, Goel R In Silico Pharmacol. 2024; 12(1):36.

PMID: 38699778 PMC: 11061056. DOI: 10.1007/s40203-024-00208-1.